Patients and physicians need better tools to make biologically-informed decisions about clinical trials.
Unlike traditional diagnostics vendors, we try to report everything we measure back to the patient and their care team.
We helped a recent patient find two new therapeutic options.
We built Valius because it's the approach we'd take for ourselves or family members with aggressive cancer.
.png)
.png)
